MicroPort CardioFlow Medtech Corporation (HKG:2160)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.150
-0.030 (-0.95%)
Apr 20, 2026, 4:08 PM HKT

HKG:2160 Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
57.0449.5447.4136.431.61
Revenue Growth (YoY)
15.16%4.47%30.28%15.14%98.56%
Cost of Revenue
19.9815.1214.9912.8912.93
Gross Profit
37.0634.4232.4323.5118.69
Selling, General & Admin
37.9630.4841.3533.7523.89
Research & Development
14.4621.0233.4732.4523.79
Other Operating Expenses
5.951.8114.2710.35-0.69
Operating Expenses
58.3753.389.176.5546.99
Operating Income
-21.31-18.89-56.67-53.04-28.31
Interest Expense
-1.41-0.52-0.55-0.75-3.09
Interest & Investment Income
7.110.412.25.63.89
Earnings From Equity Investments
-7.21-8.45-9.09-10.05-0.55
Currency Exchange Gain (Loss)
-0.0900.22-0.04-0.56
Other Non Operating Income (Expenses)
0.44-0.03-0.03-0.03-0.04
EBT Excluding Unusual Items
-22.48-17.48-53.92-58.31-28.66
Gain (Loss) on Sale of Investments
4.4511.24-11.47--
Gain (Loss) on Sale of Assets
-0.01-0.090.01-0-0.09
Asset Writedown
----7.12-
Pretax Income
-18.04-6.34-65.38-65.43-28.75
Income Tax Expense
0.790.961.120.450.1
Earnings From Continuing Operations
-18.82-7.3-66.5-65.88-28.85
Minority Interest in Earnings
0.010.52---
Net Income
-18.82-6.77-66.5-65.88-28.85
Net Income to Common
-18.82-6.77-66.5-65.88-28.85
Shares Outstanding (Basic)
492468473473466
Shares Outstanding (Diluted)
492468473473466
Shares Change (YoY)
5.20%-1.02%-0.11%1.47%36.04%
EPS (Basic)
-0.04-0.01-0.14-0.14-0.06
EPS (Diluted)
-0.04-0.01-0.14-0.14-0.06
Free Cash Flow
--36.98-33.13-33.13-38.55
Free Cash Flow Per Share
--0.08-0.07-0.07-0.08
Gross Margin
64.97%69.48%68.39%64.59%59.11%
Operating Margin
-37.35%-38.13%-119.52%-145.74%-89.54%
Profit Margin
-32.99%-13.68%-140.25%-181.01%-91.26%
Free Cash Flow Margin
--74.65%-69.87%-91.02%-121.97%
EBITDA
-17.14-14.9-53.21-50.44-27.39
EBITDA Margin
-30.05%-30.08%-112.22%-138.60%-86.64%
D&A For EBITDA
4.163.993.462.60.92
EBIT
-21.31-18.89-56.67-53.04-28.31
EBIT Margin
-37.35%-38.13%-119.52%-145.74%-89.54%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.